SLF1081851

N/A

Report date: 2022/08/30 16:40:41
NME

Base Information

Drug NameSLF1081851
Drug Alias NameSLF-1081851
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine-1-phosphate transporter SPNS2 inhibitors
TargetsSphingosine-1-phosphate transporter SPNS2
Therapy Area/IndicationsRenal fibrosisNephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Virginia
Inactive CompaniesN/A
Active IndicationsRenal fibrosisNephritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A